GlaxoSmithKline Plc pulled ahead in the second quarter recording a rise in turnover of 6% to £8.1 billion. This followed a double-digit decline in the first three months of the year. Operating profit for the latest quarter was £1.7 billion, down by 41% from the previous year, when the company recorded one-off income from several asset disposals.
